CAN STORAGE OF THAWED CRYOPRECIPITATE BE EXTENDED TO MORE THAN 6 HOURS

被引:11
作者
SAXENA, S
ODONO, V
FRANCIS, RB
ENDAHL, GL
SHULMAN, IA
机构
[1] UNIV SO CALIF,LOS ANGELES CTY MED CTR,CHEM PATHOL SECT,LOS ANGELES,CA 90033
[2] UNIV SO CALIF,LOS ANGELES CTY MED CTR,TRANSFUS MED & BLOOD BANK SECT,LOS ANGELES,CA 90033
[3] UNIV SO CALIF,LOS ANGELES CTY MED CTR,COAGULAT SECT PATHOL,LOS ANGELES,CA 90033
[4] UNIV SO CALIF,DEPT PATHOL,LOS ANGELES,CA 90089
[5] UNIV SO CALIF,DEPT MED,LOS ANGELES,CA 90089
关键词
Cryoprecipitate; Factor VIII; FFP; Fibrinogen;
D O I
10.1093/ajcp/94.2.203
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Fresh-frozen plasma (FFP) and cyroprecipitate both contain Factors I and VIII, however, thawed FFP may be stored at 1-6°C for 24 hours, but thawed cryoprecipitate may only be stored at 1-6°C for six hours when used for Factor VIII content. To determine whether it would be safe and effective to extend the storage period of thawed cryoprecipitate from 6 to 24 hours, Factor VIII (and fibrinogen) levels were measured in 25 units of cryoprecipitates immediately on thawing and at 6 hours and 24 hours thereafter. The Factor VIII activity level decreased to 86% of the original activity level within 6 hours, but the drop between 6 and 24 hours was relatively small. Eighty percent of the original activity was still present at 24 hours after thawing. The fibrinogen level decreased to 87% of the original level within 6 hours but remained stable between 6 and 24 hours. Additional testing showed that fibrinogen levels remained stable between 6 and 74 hours. These data suggested that the storage of thawed cryoprecipitate might be extended to 24 hours when this blood product is used for Factor VIII content and to 74 hours when it is used for fibrinogen content. Furthermore, the lack of prohibition on the use of cryoprecipitate that has been thawed for more than six hours and stored at 4°C for its fibrinogen content seems reasonable.
引用
收藏
页码:203 / 206
页数:4
相关论文
共 8 条
  • [1] PROTOCOL FOR CRYOPRECIPITATE PRODUCTION
    BURKA, ER
    HARKER, LA
    KASPER, CK
    KEVY, SV
    NESS, PM
    [J]. TRANSFUSION, 1975, 15 (04) : 307 - 311
  • [2] STABILITY OF FACTOR-V AND FACTOR-VIII IN THAWED FRESH-FROZEN PLASMA UNITS
    MILAM, JD
    BUZZURRO, CJ
    AUSTIN, SF
    STANSBERRY, SW
    [J]. TRANSFUSION, 1980, 20 (05) : 546 - 548
  • [3] FIBRINOGEN IN CRYOPRECIPITATE AND ITS RELATIONSHIP TO FACTOR-VIII (AHF) LEVELS
    NESS, PM
    PERKINS, HA
    [J]. TRANSFUSION, 1980, 20 (01) : 93 - 96
  • [4] RAPID CONTROLLED THAWING OF FRESH-FROZEN PLASMA IN A MODIFIED MICROWAVE-OVEN
    ROCK, G
    TACKABERRY, ES
    DUNN, JG
    KASHYAP, S
    [J]. TRANSFUSION, 1984, 24 (01) : 60 - 65
  • [5] SCHIFFMAN S, 1959, BRIT J HAEMATOL, V5, P17
  • [6] CHANGES IN PLASMA COAGULATION-FACTORS DURING BLOOD-STORAGE
    SIMON, TL
    [J]. PLASMA THERAPY & TRANSFUSION TECHNOLOGY, 1988, 9 (03): : 309 - 315
  • [7] FIBRONECTIN - APPLICATIONS TO CLINICAL MEDICINE
    SNYDER, EL
    LUBAN, NLC
    [J]. CRC CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 1986, 23 (01): : 15 - 34
  • [8] 1988, AABB NEWS BRIEFS NOV